<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2022-28-3-270-279</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-2150</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group></article-categories><title-group><article-title>Пароксизмальная фибрилляция предсердий и структурно-функциональное состояние левых отделов сердца у больных артериальной гипертензией</article-title><trans-title-group xml:lang="en"><trans-title>Paroxysmal atrial fibrillation and the left heart structure and function in hypertensive patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8879-3791</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мазур</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Mazur</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мазур Евгений Станиславович—доктор медицинских наук, заведующий кафедрой госпитальной терапии и профессиональных болезней</p><p>ул. Советская, д. 4, Тверь, 170100</p></bio><bio xml:lang="en"><p>Eugenie S. Mazur, MD, PhD, DSc, Head, Department of Internal Diseases and Occupational Diseases</p><p>4 Sovetskaya street, Tver, 170100</p></bio><email xlink:type="simple">mazur-tver@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4818-434X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мазур</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mazur</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мазур Вера Вячеславовна — доктор медицинских наук, профессор кафедры госпитальной терапии и профессиональных болезней</p><p>Тверь</p></bio><bio xml:lang="en"><p>Vera V. Mazur, MD, PhD, DSc, Professor, Department of Internal Diseases and Occupational Diseases</p><p>Tver</p><p> </p></bio><email xlink:type="simple">Vera.v.mazur@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0511-7366</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баженов</surname><given-names>Н. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Bazhenov</surname><given-names>N. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Баженов Николай Дмитриевич — кандидат медицинских наук, доцент кафедры госпитальной терапии и профессиональных болезней</p><p>Тверь</p></bio><bio xml:lang="en"><p>Nikolay D. Bazhenov, MD, PhD, Associate Professor, Department of Internal Diseases and Occupational Diseases</p><p>Tver</p></bio><email xlink:type="simple">bazhenovnd@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0648-5358</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нилова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nilova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нилова Оксана Владимировна — кандидат медицинских наук, доцент кафедры поликлинической терапии и семейной медицины</p><p>Тверь</p></bio><bio xml:lang="en"><p>Oksana V. Nilova, MD, PhD, Associate Professor, Department of Polyclinic Therapy and Family Medicine</p><p>Tver</p></bio><email xlink:type="simple">tevirp69@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3941-2550</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бурова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Burova</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бурова Светлана Александровна — кандидат медицинских наук, кардиолог</p><p>Москва</p></bio><bio xml:lang="en"><p>Svetlana A. Burova, MD, PhD, Cardiologist</p><p>Moscow</p></bio><email xlink:type="simple">sabdok80@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Тверской государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tver State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Государственное бюджетное учреждение здравоохранения «Городская клиническая больница имени М.Е. Жадкевича» Департамента здравоохранения</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Zhadkevich Moscow City Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>28</day><month>02</month><year>2022</year></pub-date><volume>28</volume><issue>3</issue><fpage>270</fpage><lpage>279</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мазур Е.С., Мазур В.В., Баженов Н.Д., Нилова О.В., Бурова С.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Мазур Е.С., Мазур В.В., Баженов Н.Д., Нилова О.В., Бурова С.А.</copyright-holder><copyright-holder xml:lang="en">Mazur E.S., Mazur V.V., Bazhenov N.D., Nilova O.V., Burova S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/2150">https://htn.almazovcentre.ru/jour/article/view/2150</self-uri><abstract><p>Цель исследования — выявить особенности структурно-функционального состояния левых отделов сердца у больных артериальной гипертензией (АГ) с впервые выявленными пароксизмами фибрилляции предсердий (ФП).</p><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование включались больные АГ с гипертрофией левого желудочка (ГЛЖ), которым в течение последнего месяца было выполнено суточное мониторирование электрокардиограммы (ЭКГ). Пациенты без зарегистрированных эпизодов ФП (возраст от 37 до 82 лет, мужчин 38,4%) были разделены на две группы: в 1-ю вошли 32 пациента в возрасте до 55 лет, во 2-ю — 63 пациента в возрасте 55 лет и старше. Все 38 пациентов с выявленными при холтеровском мониторировании пароксизмами ФП были включены в 3-ю группу (возраст от 56 до 74 лет, мужчин 28,9%). При трансторакальном эхокардиографическом исследовании у всех больных определялись показатели структурно-функционального состояния левых отделов сердца, включая глобальный стрейн левого желудочка и стрейн левого предсердия в фазы резервуара и сокращения.</p></sec><sec><title>Результаты</title><p>Результаты. Средний возраст больных в выделенных группах составил 44,7 46,4 48,2 против 61,9 63,7 65,4 и 63,4 64,8 66,2 года (р &lt; 0,001), длительность АГ — 3,2 4,3 5,6 против 6,9 7,9 9,1 и 5,7 6,9 8,1 года (р &lt; 0,001). У больных 1-й группы значительно реже, чем в других группах, отмечалась ГЛЖ 2-й и 3-й степени (5,0 12,5 28,1%против 43,3 55,667,8% и 36,8 52,668,5%, p &lt; 0,001) и нарушение его диастолической функции (5,2 18,8 32,3% против 51,6 63,5 75,4% и 53,6 68,4 83,2%, p &lt; 0,001). Стрейн левого предсердия в фазу резервуара в 1-й группе был выше, чем во 2-й, а во 2-й — выше, чем в 3-й (24,7 26,328,0 против 21,5 22,723,9 против 17,8 19,220,5, р &lt; 0,001). Стрейн в фазу сокращения в 1-й и 2-й группах не различался и был выше, чем в 3-й (13,8 14,9 16,0 и 12,9 13,6 14,2 против 9,6 10,3 11,1, р &lt; 0,001). Анализ многофакторной логистической регрессии показал, что у больных АГ в возрасте 55 лет и старше на вероятность выявления пароксизмов ФП при холтеровском мониторировании влияет стрейн левого предсердия в фазу сокращения. При значении этого показателя менее 13% шансы выявления ФП у таких больных возрастают в 3,122 9,21127,171 раза (р &lt; 0,001).</p></sec><sec><title>Заключение</title><p>Заключение. При сопоставимом возрасте и состоянии левого желудочка сердца показатели деформации левого предсердия у больных АГ с ГЛЖ и пароксизмальной ФП существенно ниже, чем у больных без нарушений сердечного ритма. У больных АГ в возрасте 55 лет и старше стрейн левого предсердия в фазу сокращения менее 13% служит предиктором выявления у больных АГ пароксизмов ФП при суточном мониторировании ЭКГ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To identify the features of the left heart structure and function in patients with hypertension (HTN) and new onset paroxysmal atrial fibrillation (AF).</p></sec><sec><title>Design and methods</title><p>Design and methods. We included HTN patients with left ventricular hypertrophy and valid 24-hour Holter monitoring carried out over the last month. Patients without AF paroxysms (age from 37 to 82 years, 38,4% men) were divided into two groups: the 1st group included 32 patients under 55 years of age, the 2nd group comprised 63 patients 55 years of age and older. Thirty-eight patients with AF paroxysms were included in the 3rd group (age from 56 to 74 years, men 28,9%). The parameters of the left heart structure and function, including the global longitudinal strain of the left ventricle and the left atrium strain in the reservoir and contraction phases, were assessed by echocardiography.</p></sec><sec><title>Results</title><p>Results. The average age of patients in the groups was 44,7 46,4 48,2 vs 61,9 63,7 65,4 vs 63,4 64,8 66,2 years (p &lt; 0,001), and the average duration of HTN was 3,2 4,35,6 vs 6,9 7,99,1 vs 5,7 6,98,1 years (p &lt; 0,001), respectively. The moderate and severe left ventricular hypertrophy and the diastolic dysfunction were found significantly less frequently in the 1st group than in other groups (5,0 12,528,1% vs 43,3 55,667,8% vs 36,8 52,668,5%, p &lt; 0,001 and 5,2 18,832,3% vs 51,6 63,575,4% vs 53,6 68,483,2%, p &lt; 0,001). In 1st group, the left atrial reservoir strain was higher than in the 2nd group, and in the 2nd group it was higher than in the 3rd group (24,7 26,3 28,0 vs 21,5 22,7 23,9 vs 17,8 19,2 20,5, p &lt; 0,001). The left atrial contraction strain did not differ in the 1st and 2nd groups and it was higher than in the 3rd group (13,8 14,9 16,0 and 12,9 13,6 14,2 vs 9,6 10,3 11,1, p &lt; 0,001). The multivariate logistic regression analysis showed that the left atrial strain in the contraction phase is a predictor of AF occurrence in HTN patients over 55 years old depends on. The chances of AF detecting in these patients increase by 3,122 9,21127,171 times (p &lt; 0,001), if the left atrial strain in the contraction phase is below 13%.</p></sec><sec><title>Conclusions</title><p>Conclusions. The left atrial strain in HTN patients with paroxysmal AF are significantly lower than in patients without cardiac arrhythmias independently of age and the left ventricular state. The left atrial contraction strain ≤ 13% is a predictor of the detection of AF paroxysms during 24-hour Holter monitoring in HTN patients aged 55 years and older.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>пароксизмальная фибрилляция предсердий</kwd><kwd>деформация миокарда левого предсердия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypertension</kwd><kwd>paroxysmal atrial fibrillation</kwd><kwd>the left atrial strain</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612</mixed-citation><mixed-citation xml:lang="en">Atrial fibrillation and flatter. Clinical guidelines of the Ministry of Health of the Russian Federation (2020). Available from: http://cr.rosminzdrav.ru/recomend/382_1. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Фибрилляция и трепетание предсердий. Клинические рекомендации Министерства здравоохранения Российской Федерации (2020). Доступно на: http://cr.rosminzdrav.ru/recomend/382_1.</mixed-citation><mixed-citation xml:lang="en">Atrial fibrillation and flatter. Clinical guidelines of the Ministry of Health of the Russian Federation (2020). Available from: http://cr.rosminzdrav.ru/recomend/382_1. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A et al. ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120– 129. doi:10.1056/NEJMoa1105575</mixed-citation><mixed-citation xml:lang="en">Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A et al. ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120– 129. doi:10.1056/NEJMoa1105575</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Potpara TS, Polovina MM, Marinkovic JM, Lip GY. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol. 2013;168(5):4744–4749. doi:10.1016/j.ijcard.2013.07.234</mixed-citation><mixed-citation xml:lang="en">Potpara TS, Polovina MM, Marinkovic JM, Lip GY. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol. 2013;168(5):4744–4749. doi:10.1016/j.ijcard.2013.07.234</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Khurshid S, Healey JS, McIntyred WF, Lubitz SA. Population-based screening for atrial fibrillation. Circ Res. 2020;127(1):143–154. doi:10.1161/CIRCRESAHA.120.316341</mixed-citation><mixed-citation xml:lang="en">Khurshid S, Healey JS, McIntyred WF, Lubitz SA. Population-based screening for atrial fibrillation. Circ Res. 2020;127(1):143–154. doi:10.1161/CIRCRESAHA.120.316341</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Petre I, Onciul S, Iancovici S, Zamfir D, Stoian M, Scarlatescu A et al. Left atrial strain for predicting atrial fibrillation onset in hypertensive patients. High Blood Press Cardiovasc Prev. 2019;26(4):331–337. doi:10.1007/s40292-019-00326-4</mixed-citation><mixed-citation xml:lang="en">Petre I, Onciul S, Iancovici S, Zamfir D, Stoian M, Scarlatescu A et al. Left atrial strain for predicting atrial fibrillation onset in hypertensive patients. High Blood Press Cardiovasc Prev. 2019;26(4):331–337. doi:10.1007/s40292-019-00326-4</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Patel RB, Delaney JA, Hu M, Patel H, Cheng J, GottdienerJ et al. Characterization of cardiac mechanics and incident atrial fibrillation in participants of the Cardiovascular Health Study. JCI Insight. 2020;5(19): e141656. doi:10.1172/jci.insight.141656</mixed-citation><mixed-citation xml:lang="en">Patel RB, Delaney JA, Hu M, Patel H, Cheng J, GottdienerJ et al. Characterization of cardiac mechanics and incident atrial fibrillation in participants of the Cardiovascular Health Study. JCI Insight. 2020;5(19): e141656. doi:10.1172/jci.insight.141656</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kawakami H, Ramkumar S, Pathan F, Wright L, Marwick TH. Use of echocardiography to stratify the risk of atrial fibrillation: comparison of left atrial and ventricular strain. Eur Heart J Cardiovasc Imaging, 2020;21(4):399–407. doi:10.1093/ehjci/jez240</mixed-citation><mixed-citation xml:lang="en">Kawakami H, Ramkumar S, Pathan F, Wright L, Marwick TH. Use of echocardiography to stratify the risk of atrial fibrillation: comparison of left atrial and ventricular strain. Eur Heart J Cardiovasc Imaging, 2020;21(4):399–407. doi:10.1093/ehjci/jez240</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for cardiac camber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270. doi:10.1093/ehjci/jev014</mixed-citation><mixed-citation xml:lang="en">Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for cardiac camber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270. doi:10.1093/ehjci/jev014</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–1360. doi:10.1093/ehjci/jew082</mixed-citation><mixed-citation xml:lang="en">Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–1360. doi:10.1093/ehjci/jew082</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of CardioVascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr. 2015;28(7):727–54. doi:10.1016/j.echo.2015.05.002</mixed-citation><mixed-citation xml:lang="en">Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of CardioVascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr. 2015;28(7):727–54. doi:10.1016/j.echo.2015.05.002</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R et al. Definition for a common standard for 2D speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2015;16(1):1–11. doi:10.1093/ehjci/jeu184</mixed-citation><mixed-citation xml:lang="en">Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R et al. Definition for a common standard for 2D speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2015;16(1):1–11. doi:10.1093/ehjci/jeu184</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Badano LP, Kolias T, Muraru D, Abraham TP, Aurigemma G, Edvardsen T et al. Standardization of left atrial, right ventricular and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2018;19(6):591–600. doi:10.1093/ehjci/jey042</mixed-citation><mixed-citation xml:lang="en">Badano LP, Kolias T, Muraru D, Abraham TP, Aurigemma G, Edvardsen T et al. Standardization of left atrial, right ventricular and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2018;19(6):591–600. doi:10.1093/ehjci/jey042</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138(9):861–870. doi:10.1161/CIRCULATIONAHA.118.034646</mixed-citation><mixed-citation xml:lang="en">Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138(9):861–870. doi:10.1161/CIRCULATIONAHA.118.034646</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Moura B, Aimo A, Al-Mohammad A, Flammer A, Barberis V, Bayes-Genis A et al. Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2021;23(10):1577–1596. doi:10.1002/ejhf.2339</mixed-citation><mixed-citation xml:lang="en">Moura B, Aimo A, Al-Mohammad A, Flammer A, Barberis V, Bayes-Genis A et al. Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2021;23(10):1577–1596. doi:10.1002/ejhf.2339</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339</mixed-citation><mixed-citation xml:lang="en">Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hennawy B, Kilany W, Galal H, Mamdouh A. Role of speckle tracking echocardiography in detecting early left atrial dysfunction in hypertensive patients. Egypt Heart J. 2018;70(3):217–223. doi:10.1016/j.ehj.2018.05.004</mixed-citation><mixed-citation xml:lang="en">Hennawy B, Kilany W, Galal H, Mamdouh A. Role of speckle tracking echocardiography in detecting early left atrial dysfunction in hypertensive patients. Egypt Heart J. 2018;70(3):217–223. doi:10.1016/j.ehj.2018.05.004</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lin KB, Chen KK, Li S, Cai MQ, Yuan MJ, Wang YP et al. Impaired left atrial performance resulting from age-related arial fibrillation is associated with increased fibrosis burden: Insights From a Clinical Study Combining With an in vivo Experiment. Front Cardiovasc Med. 2021;7:615065. doi:10.3389/fcvm.2020.615065</mixed-citation><mixed-citation xml:lang="en">Lin KB, Chen KK, Li S, Cai MQ, Yuan MJ, Wang YP et al. Impaired left atrial performance resulting from age-related arial fibrillation is associated with increased fibrosis burden: Insights From a Clinical Study Combining With an in vivo Experiment. Front Cardiovasc Med. 2021;7:615065. doi:10.3389/fcvm.2020.615065</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ma J, Chen Q, Ma S. Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management. J Cell Mol Med. 2021;25(6):2764–2775. doi:10.1111/jcmm.16350</mixed-citation><mixed-citation xml:lang="en">Ma J, Chen Q, Ma S. Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management. J Cell Mol Med. 2021;25(6):2764–2775. doi:10.1111/jcmm.16350</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yong KW, Li YH, Huang GY, Lu TJ, Safwani WK, Pingguan-Murphy B et al. Mechanoregulation of cardiac myofibroblast differentiation: implications for cardiac fibrosis and therapy. Am J Physiol Heart Circ Physiol. 2015;309(4):H532–H542. doi:10.1152/ajpheart.00299.2015</mixed-citation><mixed-citation xml:lang="en">Yong KW, Li YH, Huang GY, Lu TJ, Safwani WK, Pingguan-Murphy B et al. Mechanoregulation of cardiac myofibroblast differentiation: implications for cardiac fibrosis and therapy. Am J Physiol Heart Circ Physiol. 2015;309(4):H532–H542. doi:10.1152/ajpheart.00299.2015</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tarbit E, Singh I, Peart JN, Rose’Meyer RB. Biomarkers for the identification of cardiac fibroblast and myofibroblast cells. Heart Fail Rev. 2019;24(1):1–15. doi:10.1007/s10741-018-9720-1</mixed-citation><mixed-citation xml:lang="en">Tarbit E, Singh I, Peart JN, Rose’Meyer RB. Biomarkers for the identification of cardiac fibroblast and myofibroblast cells. Heart Fail Rev. 2019;24(1):1–15. doi:10.1007/s10741-018-9720-1</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
